<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRA</journal-id>
<journal-id journal-id-type="hwp">spjra</journal-id>
<journal-id journal-id-type="nlm-ta">J Renin Angiotensin Aldosterone Syst</journal-id>
<journal-title>Journal of the Renin-Angiotensin-Aldosterone System</journal-title>
<issn pub-type="ppub">1470-3203</issn>
<issn pub-type="epub">1752-8976</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1470320311426168</article-id>
<article-id pub-id-type="publisher-id">10.1177_1470320311426168</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>No association between <italic>ACE</italic> olymorphism and risk of nasopharyngeal carcinoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Zhao-Hui</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311426168">1</xref>
<xref ref-type="fn" rid="fn1-1470320311426168">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pan</surname><given-names>Xin-Min</given-names></name>
<xref ref-type="aff" rid="aff2-1470320311426168">2</xref>
<xref ref-type="fn" rid="fn1-1470320311426168">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Han</surname><given-names>Bao-Wei</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311426168">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Han</surname><given-names>Hong-bin</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311426168">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Zhen</given-names></name>
<xref ref-type="aff" rid="aff2-1470320311426168">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gao</surname><given-names>Lin-Bo</given-names></name>
<xref ref-type="aff" rid="aff3-1470320311426168">3</xref>
<xref ref-type="fn" rid="fn1-1470320311426168">*</xref>
</contrib>
</contrib-group>
<aff id="aff1-1470320311426168"><label>1</label>Secondary Department of General Surgery, Luo Yang Central Hospital, PR China</aff>
<aff id="aff2-1470320311426168"><label>2</label>Department of Forensic Pathology, College of Forensic Medicine, Henan University of Science and Technology, PR China</aff>
<aff id="aff3-1470320311426168"><label>3</label>Laboratory of Molecular and Translational Medicine, West China Institute of Women and Children’s Health, West China Second University Hospital, Sichuan University, PR China</aff>
<author-notes>
<corresp id="corresp1-1470320311426168">Lin-Bo Gao, Laboratory of Molecular and Translational Medicine, West China Institute of Women and Children’s Health, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, PR China Email: <email>cdchglb@gmail.com</email></corresp>
<fn fn-type="other" id="fn1-1470320311426168">
<label>*</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>13</volume>
<issue>1</issue>
<fpage>210</fpage>
<lpage>215</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Emerging evidence has shown that angiotensin I-converting enzyme (ACE) plays pivotal roles not only in the regulation of cardiovascular homeostasis but also in the process of tumorigenesis. A common <italic>ACE</italic> I/D polymorphism has been found to be functional, with the D allele displaying a higher plasma ACE level and ACE activity. The purpose of this study was to investigate whether the <italic>ACE</italic> I/D polymorphism was related to the risk of nasopharyngeal carcinoma (NPC). The study included 175 patients with NPC and 279 age- and sex-matched control subjects. The <italic>ACE</italic> I/D polymorphism was identified by a polymerase chain reaction analysis. No association was found between the <italic>ACE</italic> I/D polymorphism and risk of NPC (ID vs. II: odds ratio [OR] = 0.77, 95% confidence interval [CI] 0.51–1.17; DD vs. II: OR = 0.98, 95%CI 0.56–1.72, respectively). This finding indicates that the <italic>ACE</italic> I/D polymorphism may not play a role in susceptibility to NPC. Further studies are warranted to confirm this finding, especially in ethnically disparate populations.</p>
</abstract>
<kwd-group>
<kwd>ACE</kwd>
<kwd>nasopharyngeal carcinoma</kwd>
<kwd>polymorphism</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1470320311426168" sec-type="intro">
<title>Introduction</title>
<p>Nasopharyngeal carcinoma (NPC) is a malignancy originating in the nasopharynx with a distinct geographical distribution. Although it is rare in most parts of the world, it is extremely common in southern China, where the annual incidence is about 25 times higher than in the rest of the world.<sup><xref ref-type="bibr" rid="bibr1-1470320311426168">1</xref>,<xref ref-type="bibr" rid="bibr2-1470320311426168">2</xref></sup> In past years, many risk factors for the development of NPC have been widely accepted, including Epstein–Barr virus infection, intake of salted fish, and tobacco smoking.<sup><xref ref-type="bibr" rid="bibr3-1470320311426168">3</xref>–<xref ref-type="bibr" rid="bibr5-1470320311426168">5</xref></sup> However, only a small fraction of individuals suffer from the disease in the endemic regions, even though all the people are exposed to the same risk factors, suggesting that a genetic factor, such as a single nucleotide polymorphism, may influence individual susceptibility to NPC. Our previous studies have shown that <italic>IL-16</italic> and <italic>NFKB1</italic> gene polymorphisms may contribute to the development of NPC.<sup><xref ref-type="bibr" rid="bibr6-1470320311426168">6</xref>,<xref ref-type="bibr" rid="bibr7-1470320311426168">7</xref></sup></p>
<p>Angiotensin I-converting enzyme (ACE) is a key component of the renin–angiotensin system (RAS) and catalyzes the conversion of angiotensin I to angiotensin II. Angiotensin II has been reported to be involved in tumorigenesis, including tumor cell proliferation, angiogenesis, migration, and metastatic behavior.<sup><xref ref-type="bibr" rid="bibr8-1470320311426168">8</xref></sup> Growing evidence has shown that ACE levels are differentially expressed in several cancers and that administration of ACE inhibitors could attenuate tumor growth in experimental studies.<sup><xref ref-type="bibr" rid="bibr9-1470320311426168">9</xref>,<xref ref-type="bibr" rid="bibr10-1470320311426168">10</xref></sup> These observations imply that <italic>ACE</italic> may be a candidate cancer gene.</p>
<p>The gene encoding ACE is located on the long arm of chromosome 17 (17q23) in humans and contains 26 exons and 25 introns. A common insertion/deletion (I/D) polymorphism in the non-coding region of the <italic>ACE</italic> gene was identified in 1990.<sup><xref ref-type="bibr" rid="bibr11-1470320311426168">11</xref></sup> The I allele results from the presence of a 287bp DNA fragment in intron 16, and the D allele results from the absence of this DNA sequence.<sup><xref ref-type="bibr" rid="bibr11-1470320311426168">11</xref></sup> It has been reported that individuals with the D allele have higher plasma ACE activity.<sup><xref ref-type="bibr" rid="bibr11-1470320311426168">11</xref>–<xref ref-type="bibr" rid="bibr13-1470320311426168">13</xref></sup> Recently, numerous studies have been carried out to examine the association between the <italic>ACE</italic> I/D polymorphism and susceptibility to a range of cancers, including breast cancer,<sup><xref ref-type="bibr" rid="bibr14-1470320311426168">14</xref>–<xref ref-type="bibr" rid="bibr21-1470320311426168">21</xref></sup> gastric cancer,<sup><xref ref-type="bibr" rid="bibr22-1470320311426168">22</xref>–<xref ref-type="bibr" rid="bibr26-1470320311426168">26</xref></sup> colorectal cancer,<sup><xref ref-type="bibr" rid="bibr27-1470320311426168">27</xref>–<xref ref-type="bibr" rid="bibr31-1470320311426168">31</xref></sup> prostate cancer,<sup><xref ref-type="bibr" rid="bibr32-1470320311426168">32</xref>–<xref ref-type="bibr" rid="bibr34-1470320311426168">34</xref></sup> lung cancer,<sup><xref ref-type="bibr" rid="bibr35-1470320311426168">35</xref>,<xref ref-type="bibr" rid="bibr36-1470320311426168">36</xref></sup> oral cancer,<sup><xref ref-type="bibr" rid="bibr37-1470320311426168">37</xref>,<xref ref-type="bibr" rid="bibr38-1470320311426168">38</xref></sup> and renal cancer.<sup><xref ref-type="bibr" rid="bibr39-1470320311426168">39</xref></sup> No studies to date have evaluated the relationship between the <italic>ACE</italic> I/D polymorphism and NPC risk. In this case–control study, we aimed to explore whether the <italic>ACE</italic> I/D polymorphism is associated with susceptibility to NPC in a Chinese population.</p>
</sec>
<sec id="section2-1470320311426168" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-1470320311426168">
<title>Study population</title>
<p>The study protocol was approved by the hospital ethics committee and all subjects provided informed consent. One hundred and seventy-five NPC patients (mean age: 45.6 ± 11.6 years) and 279 control subjects (mean age: 43.3 ± 12.7 years) were enrolled in this study between July 2006 and September 2010 (<xref ref-type="table" rid="table1-1470320311426168">Table 1</xref>). All subjects were genetically unrelated Chinese individuals residing in Luo Yang Central Hospital. The diagnosis of NPC was confirmed by histopathological examination. Patients with recurring NPC or NPC occurring in combination with other cancers were excluded. Healthy individuals without any evidence of personal or family history of cancer were defined as controls. The controls were frequency-matched to the cases based on age, sex, and residential area.</p>
<table-wrap id="table1-1470320311426168" position="float">
<label>Table 1.</label>
<caption><p>Characteristics of the study population.</p></caption>
<graphic alternate-form-of="table1-1470320311426168" xlink:href="10.1177_1470320311426168-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="left">NPC patients (<italic>n</italic> = 175)</th>
<th align="left">Controls (<italic>n</italic> = 279)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (years ± SD)</td>
<td>45.6 ± 11.6</td>
<td>43.3 ± 12.7</td>
</tr>
<tr>
<td colspan="3">Sex</td>
</tr>
<tr>
<td> Male</td>
<td>129 (73.7%)</td>
<td>207 (74.2%)</td>
</tr>
<tr>
<td> Female</td>
<td>46 (26.3%)</td>
<td>72 (25.8%)</td>
</tr>
<tr>
<td colspan="3">Clinical stages</td>
</tr>
<tr>
<td> I–II</td>
<td>27 (15.4%)</td>
<td>-</td>
</tr>
<tr>
<td> III–IV</td>
<td>148 (84.6%)</td>
<td>-</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1470320311426168"><p>NPC: nasopharyngeal carcinoma, SD, standard deviation.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section4-1470320311426168">
<title>Genotyping</title>
<p>Genomic DNA was extracted from peripheral blood by using a DNA isolation kit (Bioteke Corporation, Beijing, China). The polymerase chain reaction (PCR) – polyacrylamide gel electrophoresis (PAGE) method was used to genotype the <italic>ACE</italic> I/D polymorphism. The PCR primers were based on Ruggenenti et al.<sup><xref ref-type="bibr" rid="bibr40-1470320311426168">40</xref></sup> PCR reaction was performed in a total volume of 10 µl containing 1.0 µl 10 × PCR buffer, 0.15 mmol/l deoxy-ribonucleoside triphosphates (dNTPs), 1.5 mmol/l MgCl<sub>2</sub>, 0.1 µl each primer, 50 ng genomic DNA and 0.3 U of Taq DNA polymerase. The reactions were run under the following conditions: initial denaturation at 94°C for 4 min, followed by 35 cycles of 30 s at 94°C, 90 s at 64°C and 90 s at 72°C, and a final elongation at 72°C for 10 min. There is a possibility of misclassification of the ID heterozygote as DD homozygote due to preferentially amplifying the D allele. An additional PCR, therefore, was conducted to avoid the misclassification. The PCR procedure was described previously.<sup><xref ref-type="bibr" rid="bibr41-1470320311426168">41</xref></sup> All PCR products were visualized after electrophoresis on 6% polyacrylamide gel with silver nitrate staining.</p>
</sec>
<sec id="section5-1470320311426168">
<title>Statistical analysis</title>
<p>All analyses were done by the SPSS statistical software package version 11.5 (SPSS Inc., Chicago, IL, USA). Hardy–Weinberg equilibrium was assessed by the χ<sup>2</sup> test. Continuous variables were compared using the unpaired Student’s <italic>t</italic>-test. The distribution of genotype and allele frequencies of <italic>ACE</italic> I/D polymorphism between NPC cases and controls was compared using the χ<sup>2</sup> test. The strength of the gene–cancer association was estimated by computing odds ratio (OR) and 95% confidence intervals (CI). All <italic>p</italic> values were two-sided, and statistical significance was set at <italic>p</italic> &lt; 0.05.</p>
</sec></sec>
<sec id="section6-1470320311426168" sec-type="results">
<title>Results</title>
<p>The genotype and allele frequencies of the <italic>ACE</italic> I/D polymorphism in NPC patients and controls are summarized in <xref ref-type="table" rid="table2-1470320311426168">Table 2</xref>. Genotype distributions did not deviate from Hardy–Weinberg equilibrium in either cases or controls. The frequencies of the II, ID, and DD genotypes were 33.7, 50.9, and 15.4% in controls and 38.3, 44.6, and 17.1% in NPC patients, respectively. No significant association was observed between the <italic>ACE</italic> I/D polymorphism and risk of NPC (ID vs. II: OR = 0.77, 95%CI 0.51–1.17; DD vs. II: OR = 0.98, 95%CI 0.56–1.72, respectively).</p>
<table-wrap id="table2-1470320311426168" position="float">
<label>Table 2.</label>
<caption><p>The association between the <italic>ACE</italic> I/D polymorphism and NPC risk.</p></caption>
<graphic alternate-form-of="table2-1470320311426168" xlink:href="10.1177_1470320311426168-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Control, <italic>n</italic> = 279 (%)</th>
<th align="left">NPC, <italic>n</italic> = 175 (%)</th>
<th align="left">OR (95% CI)</th>
<th align="left"><italic>p</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5">Genotype</td>
</tr>
<tr>
<td> II</td>
<td>94 (33.7)</td>
<td>67 (38.3)</td>
<td>1.0 (Ref)</td>
<td/>
</tr>
<tr>
<td> ID</td>
<td>142 (50.9)</td>
<td>78 (44.6)</td>
<td>0.77 (0.51–1.17)</td>
<td>0.22</td>
</tr>
<tr>
<td> DD</td>
<td>43 (15.4)</td>
<td>30 (17.1)</td>
<td>0.98 (0.56–1.72)</td>
<td>0.94</td>
</tr>
<tr>
<td colspan="5">Allele</td>
</tr>
<tr>
<td> I</td>
<td>330 (59.1)</td>
<td>212 (60.6)</td>
<td>1.0 (Ref)</td>
<td/>
</tr>
<tr>
<td> D</td>
<td>228 (40.9)</td>
<td>138 (39.4)</td>
<td>0.94 (0.72–1.24)</td>
<td>0.67</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1470320311426168"><p>ACE: angiotensin I-converting enzyme, CI: confidence interval, NPC: nasopharyngeal carcinoma, OR: odds ratio</p></fn>
</table-wrap-foot></table-wrap>
</sec>
<sec id="section7-1470320311426168" sec-type="discussion">
<title>Discussion</title>
<p>Angiotensin II, a key effector of the RAS, plays important roles not only in the regulation of cardiovascular homeostasis but also in the process of tumor cell proliferation, angiogenesis, migration, and metastatic behavior.<sup><xref ref-type="bibr" rid="bibr8-1470320311426168">8</xref></sup> The generation of Ang II depends on the activity of ACE. Emerging evidence has shown that ACE is implicated in tumorigenesis. Alterations of plasma ACE that may influence cancer biology occur in several cancers.<sup><xref ref-type="bibr" rid="bibr29-1470320311426168">29</xref>,<xref ref-type="bibr" rid="bibr42-1470320311426168">42</xref></sup> The administration of ACE inhibitors had a significantly protective effect against tumor growth and angiogenesis in animal models of cancer.<sup><xref ref-type="bibr" rid="bibr9-1470320311426168">9</xref>,<xref ref-type="bibr" rid="bibr10-1470320311426168">10</xref></sup> A common <italic>ACE</italic> I/D polymorphism has been found to be functional, with the D allele displaying a higher plasma ACE level and ACE activity.<sup><xref ref-type="bibr" rid="bibr11-1470320311426168">11</xref>–<xref ref-type="bibr" rid="bibr13-1470320311426168">13</xref></sup> Recently, the polymorphism has been reported to be associated with the etiology of a variety of cancers, including breast cancer,<sup><xref ref-type="bibr" rid="bibr18-1470320311426168">18</xref>,<xref ref-type="bibr" rid="bibr19-1470320311426168">19</xref></sup> gastric cancer,<sup><xref ref-type="bibr" rid="bibr25-1470320311426168">25</xref></sup> prostate cancer,<sup><xref ref-type="bibr" rid="bibr32-1470320311426168">32</xref></sup> and oral cancer.<sup><xref ref-type="bibr" rid="bibr37-1470320311426168">37</xref></sup> Based on these backgrounds, we hypothesized that the <italic>ACE</italic> I/D polymorphism might modulate susceptibility to NPC. Nevertheless, no significant association was observed between the <italic>ACE</italic> I/D polymorphism and NPC risk, indicating that the polymorphism may not contribute to susceptibility to NPC in the Chinese population. Quanto software (Gauderman WJ, Morrison JM. QUANTO 1.2: A computer program for power and sample size calculations for genetic-epidemiology studies) was used to calculate the power of the case–control study according to the current sample size. Our study had 84% power to detect an effect of the <italic>ACE</italic> I/D polymorphism on NPC susceptibility with an estimated relative risk of 1.8 under a dominant genetic model.</p>
<p>In concordance with our findings, some authors reported that the <italic>ACE</italic> I/D polymorphism was not significantly associated with the risk of colorectal cancer,<sup><xref ref-type="bibr" rid="bibr27-1470320311426168">27</xref>,<xref ref-type="bibr" rid="bibr28-1470320311426168">28</xref>,<xref ref-type="bibr" rid="bibr30-1470320311426168">30</xref>,<xref ref-type="bibr" rid="bibr31-1470320311426168">31</xref></sup> breast cancer,<sup><xref ref-type="bibr" rid="bibr17-1470320311426168">17</xref></sup> gastric cancer,<sup><xref ref-type="bibr" rid="bibr22-1470320311426168">22</xref></sup> lung cancer,<sup><xref ref-type="bibr" rid="bibr35-1470320311426168">35</xref></sup> or renal cancer.<sup><xref ref-type="bibr" rid="bibr39-1470320311426168">39</xref></sup> In contrast to our findings, Röcken et al. reported that the <italic>ACE</italic> I/D polymorphism correlated with the number of lymph node metastases and tumor stage in gastric cancer. Patients with the II genotype were found to have a smaller number of lymph node metastases and lower clinical stage than patients with the DD genotype.<sup><xref ref-type="bibr" rid="bibr24-1470320311426168">24</xref></sup> Ebert et al. reported that the II genotype was associated with a decreased risk of gastric cancer compared with the DD genotype (OR = 0.20, 95%CI 0.08–0.54) in a German population.<sup><xref ref-type="bibr" rid="bibr25-1470320311426168">25</xref></sup> Goto et al. reported that the I/D genotype conferred a 1.59-fold greater risk of developing gastric cancer on <italic>Helicobacter pylori</italic> positive Japanese patients with atrophic gastritis.<sup><xref ref-type="bibr" rid="bibr26-1470320311426168">26</xref></sup> Sierra Diaz et al. reported that the D allele conferred a significantly higher risk of developing prostate cancer.<sup><xref ref-type="bibr" rid="bibr32-1470320311426168">32</xref></sup> Moreover, some researchers reported that the II genotype was associated with a significantly increased risk of breast cancer<sup><xref ref-type="bibr" rid="bibr18-1470320311426168">18</xref>,<xref ref-type="bibr" rid="bibr19-1470320311426168">19</xref></sup> and oral cancer.<sup><xref ref-type="bibr" rid="bibr37-1470320311426168">37</xref></sup></p>
<p>Although the reason for these discrepancies remains unknown, it is likely that the <italic>ACE</italic> I/D polymorphism may have different roles in different cancer types. This phenomenon was confirmed by a recently published meta-analysis study that reported a significantly decreased incidence of the <italic>ACE</italic> I/D polymorphism in patients with prostate cancer or breast cancer, but not in patients with colorectal cancer.<sup><xref ref-type="bibr" rid="bibr43-1470320311426168">43</xref></sup> Another important issue may be environmental factors that influence the risk for tumor development. Cancer is a multifactorial disease, and individuals with different environmental exposure may be responsible for the conflicting results. In addition, the genetic trait differences in diverse ethnicities may be a potential explanation for the inconclusive results.</p>
<p>After comparing the distribution of the <italic>ACE</italic> I/D polymorphism in diverse populations, we found that the genetic polymorphism varied significantly between different ethnic groups. The genotype and allele frequencies of the <italic>ACE</italic> I/D polymorphism in healthy controls from various populations are summarized in <xref ref-type="table" rid="table3-1470320311426168">Table 3</xref>. The detection rate of the I allele in Asians (44.7–65.7%)<sup><xref ref-type="bibr" rid="bibr44-1470320311426168">44</xref>–<xref ref-type="bibr" rid="bibr48-1470320311426168">48</xref></sup> was remarkably higher than in Caucasians (26.1–46.8%).<sup><xref ref-type="bibr" rid="bibr14-1470320311426168">14</xref>,<xref ref-type="bibr" rid="bibr19-1470320311426168">19</xref>,<xref ref-type="bibr" rid="bibr24-1470320311426168">24</xref>,<xref ref-type="bibr" rid="bibr30-1470320311426168">30</xref>,<xref ref-type="bibr" rid="bibr38-1470320311426168">38</xref>,<xref ref-type="bibr" rid="bibr39-1470320311426168">39</xref>,<xref ref-type="bibr" rid="bibr49-1470320311426168">49</xref>,<xref ref-type="bibr" rid="bibr50-1470320311426168">50</xref></sup> The heterogeneity of allelic frequency among the ethnicities may affect individual susceptibility to cancer in different ethnic groups. Replicated studies are of great value to confirm these findings.</p>
<table-wrap id="table3-1470320311426168" position="float">
<label>Table 3.</label>
<caption><p>Distribution of the <italic>ACE</italic> I/D polymorphism in different populations.</p></caption>
<graphic alternate-form-of="table3-1470320311426168" xlink:href="10.1177_1470320311426168-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Population</th>
<th align="left"><italic>n</italic></th>
<th align="left" colspan="3">Genotype</th>
<th align="left" colspan="2">Allele</th>
</tr>
<tr>
<th/>
<th/>
<th align="left">II, <italic>n</italic> (%)</th>
<th align="left">ID, <italic>n</italic> (%)</th>
<th align="left">DD, <italic>n</italic> (%)</th>
<th align="left">I, <italic>n</italic> (%)</th>
<th align="left">D, <italic>n</italic> (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Present study (Chinese Han)</td>
<td>279</td>
<td>94 (33.7)</td>
<td>142 (50.9)</td>
<td>43 (15.4)</td>
<td>330 (59.1)</td>
<td>228 (40.9)</td>
</tr>
<tr>
<td>Chinese Han<sup><xref ref-type="bibr" rid="bibr45-1470320311426168">45</xref></sup></td>
<td>189</td>
<td>78 (41.3)</td>
<td>78 (41.3)</td>
<td>33 (17.5)</td>
<td>234 (61.9)</td>
<td>144 (38.1)</td>
</tr>
<tr>
<td>Chinese Han<sup><xref ref-type="bibr" rid="bibr44-1470320311426168">44</xref></sup></td>
<td>302</td>
<td>129 (42.7)</td>
<td>130 (43.1)</td>
<td>43 (14.2)</td>
<td>388 (64.2)</td>
<td>216 (35.8)</td>
</tr>
<tr>
<td>Chinese Han<sup><xref ref-type="bibr" rid="bibr46-1470320311426168">46</xref></sup></td>
<td>236</td>
<td>52 (22.0)</td>
<td>107 (45.3)</td>
<td>77 (32.6)</td>
<td>211 (44.7)</td>
<td>261 (55.3)</td>
</tr>
<tr>
<td>Japanese<sup><xref ref-type="bibr" rid="bibr47-1470320311426168">47</xref></sup></td>
<td>750</td>
<td>315 (42.0)</td>
<td>355 (47.3)</td>
<td>80 (10.7)</td>
<td>985 (65.7)</td>
<td>515 (34.3)</td>
</tr>
<tr>
<td>Korean<sup><xref ref-type="bibr" rid="bibr48-1470320311426168">48</xref></sup></td>
<td>7232</td>
<td>2639 (36.5)</td>
<td>3549 (49.1)</td>
<td>1041 (14.4)</td>
<td>8827 (61.0)</td>
<td>5631 (39.0)</td>
</tr>
<tr>
<td>Turkish<sup><xref ref-type="bibr" rid="bibr14-1470320311426168">14</xref></sup></td>
<td>46</td>
<td>6 (13.0)</td>
<td>12 (26.1)</td>
<td>28 (60.9)</td>
<td>24 (26.1)</td>
<td>68 (73.9)</td>
</tr>
<tr>
<td>Greek and German<sup><xref ref-type="bibr" rid="bibr38-1470320311426168">38</xref></sup></td>
<td>153</td>
<td>9 (5.9)</td>
<td>66 (43.1)</td>
<td>78 (51.0)</td>
<td>84 (27.5)</td>
<td>222 (72.5)</td>
</tr>
<tr>
<td>Greek<sup><xref ref-type="bibr" rid="bibr30-1470320311426168">30</xref></sup></td>
<td>102</td>
<td>6 (5.9)</td>
<td>44 (43.1)</td>
<td>52 (51.0)</td>
<td>56 (27.5)</td>
<td>148 (72.5)</td>
</tr>
<tr>
<td>Brazilian<sup><xref ref-type="bibr" rid="bibr19-1470320311426168">19</xref></sup></td>
<td>307</td>
<td>53 (17.3)</td>
<td>113 (36.8)</td>
<td>141 (45.9)</td>
<td>219 (35.7)</td>
<td>395 (64.3)</td>
</tr>
<tr>
<td>Italian<sup><xref ref-type="bibr" rid="bibr49-1470320311426168">49</xref></sup></td>
<td>252</td>
<td>34 (13.5)</td>
<td>118 (46.8)</td>
<td>100 (39.7)</td>
<td>186 (36.9)</td>
<td>318 (63.1)</td>
</tr>
<tr>
<td>French<sup><xref ref-type="bibr" rid="bibr50-1470320311426168">50</xref></sup></td>
<td>560</td>
<td>101 (18.1)</td>
<td>288 (51.4)</td>
<td>171 (30.5)</td>
<td>490 (43.8)</td>
<td>630 (56.2)</td>
</tr>
<tr>
<td>German<sup><xref ref-type="bibr" rid="bibr24-1470320311426168">24</xref></sup></td>
<td>189</td>
<td>41 (21.7)</td>
<td>95 (50.3)</td>
<td>53 (28.0)</td>
<td>177 (46.8)</td>
<td>201 (53.2)</td>
</tr>
<tr>
<td>American<sup><xref ref-type="bibr" rid="bibr39-1470320311426168">39</xref></sup></td>
<td>553</td>
<td>101 (18.3)</td>
<td>295 (53.3)</td>
<td>157 (28.4)</td>
<td>492 (44.5)<sup><xref ref-type="table-fn" rid="table-fn3-1470320311426168">a</xref></sup></td>
<td>614 (55.5)<sup><xref ref-type="table-fn" rid="table-fn3-1470320311426168">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1470320311426168">
<label>a</label>
<p>Evaluated from published data.</p></fn>
<fn id="table-fn4-1470320311426168">
<p>ACE: angiotensin I-converting enzyme.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Some limitations should be discussed. All the participants in our study were Chinese, and thus the results of this study may not be automatically extrapolated to other ethnic groups. Moreover, gene–gene or gene–environment interactions were not considered in this study, which may restrict our comprehensive understanding of the effect of the <italic>ACE</italic> I/D polymorphism on NPC risk.</p>
<p>In summary, to our knowledge, this the first study to investigate the relationship between the <italic>ACE</italic> I/D polymorphism and the occurrence of NPC. We failed to find any association between the <italic>ACE</italic> I/D polymorphism and risk of NPC. However, additional studies are required to explore the gene–gene and gene–environment interactions in susceptibility to NPC, especially in ethnically disparate populations.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict"><p>The authors declare that they have no conflict of interest.</p></fn>
<fn fn-type="financial-disclosure"><p>This study was supported by the PhD scientific research foundation of Henan University of Science and Technology (No. 09001492).</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1470320311426168">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McDermott</surname><given-names>AL</given-names></name>
<name><surname>Dutt</surname><given-names>SN</given-names></name>
<name><surname>Watkinson</surname><given-names>JC</given-names></name>
</person-group>. <article-title>The aetiology of nasopharyngeal carcinoma</article-title>. <source>Clin Otolaryngol Allied Sci</source> <year>2001</year>; <volume>26</volume>: <fpage>82</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr2-1470320311426168">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>ET</given-names></name>
<name><surname>Adami</surname><given-names>HO</given-names></name>
</person-group>. <article-title>The enigmatic epidemiology of nasopharyngeal carcinoma</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <year>2006</year>; <volume>15</volume>: <fpage>1765</fpage>–<lpage>1777</lpage>.</citation>
</ref>
<ref id="bibr3-1470320311426168">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>DL</given-names></name>
<name><surname>Huang</surname><given-names>TB</given-names></name>
</person-group>. <article-title>A case-control study of risk factors of nasopharyngeal carcinoma</article-title>. <source>Cancer Lett</source> <year>1997</year>; <volume>117</volume>: <fpage>17</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr4-1470320311426168">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname><given-names>MC</given-names></name>
<name><surname>Yuan</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Epidemiology of nasopharyngeal carcinoma</article-title>. <source>Semin Cancer Biol</source> <year>2002</year>; <volume>12</volume>: <fpage>421</fpage>–<lpage>429</lpage>.</citation>
</ref>
<ref id="bibr5-1470320311426168">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>X</given-names></name>
<name><surname>Yan</surname><given-names>L</given-names></name>
<name><surname>Nilsson</surname><given-names>B</given-names></name>
<name><surname>Eklund</surname><given-names>G</given-names></name>
<name><surname>Drettner</surname><given-names>B</given-names></name>
</person-group>. <article-title>Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China</article-title>. <source>Acta Oncol</source> <year>1994</year>; <volume>33</volume>: <fpage>867</fpage>–<lpage>872</lpage>.</citation>
</ref>
<ref id="bibr6-1470320311426168">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gao</surname><given-names>LB</given-names></name>
<name><surname>Liang</surname><given-names>WB</given-names></name>
<name><surname>Xue</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma</article-title>. <source>Clin Chim Acta</source> <year>2009</year>; <volume>409</volume>: <fpage>132</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr7-1470320311426168">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>B</given-names></name>
<name><surname>Rao</surname><given-names>L</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma</article-title>. <source>Cancer Lett</source> <year>2009</year>; <volume>275</volume>: <fpage>72</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr8-1470320311426168">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>Y</given-names></name>
<name><surname>Ruiz-Ortega</surname><given-names>M</given-names></name>
<name><surname>Lorenzo</surname><given-names>O</given-names></name>
<name><surname>Ruperez</surname><given-names>M</given-names></name>
<name><surname>Esteban</surname><given-names>V</given-names></name>
<name><surname>Egido</surname><given-names>J</given-names></name>
</person-group>. <article-title>Inflammation and angiotensin II</article-title>. <source>Int J Biochem Cell Biol</source> <year>2003</year>; <volume>35</volume>: <fpage>881</fpage>–<lpage>900</lpage>.</citation>
</ref>
<ref id="bibr9-1470320311426168">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Volpert</surname><given-names>OV</given-names></name>
<name><surname>Ward</surname><given-names>WF</given-names></name>
<name><surname>Lingen</surname><given-names>MW</given-names></name><etal/>
</person-group>. <article-title>Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats</article-title>. <source>J Clin Invest</source> <year>1996</year>; <volume>98</volume>: <fpage>671</fpage>–<lpage>679</lpage>.</citation>
</ref>
<ref id="bibr10-1470320311426168">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshiji</surname><given-names>H</given-names></name>
<name><surname>Kuriyama</surname><given-names>S</given-names></name>
<name><surname>Kawata</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor</article-title>. <source>Clin Cancer Res</source> <year>2001</year>; <volume>7</volume>: <fpage>1073</fpage>–<lpage>1078</lpage>.</citation>
</ref>
<ref id="bibr11-1470320311426168">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rigat</surname><given-names>B</given-names></name>
<name><surname>Hubert</surname><given-names>C</given-names></name>
<name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name>
<name><surname>Cambien</surname><given-names>F</given-names></name>
<name><surname>Corvol</surname><given-names>P</given-names></name>
<name><surname>Soubrier</surname><given-names>F</given-names></name>
</person-group>. <article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels</article-title>. <source>J Clin Invest</source> <year>1990</year>; <volume>86</volume>: <fpage>1343</fpage>–<lpage>1346</lpage>.</citation>
</ref>
<ref id="bibr12-1470320311426168">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakai</surname><given-names>K</given-names></name>
<name><surname>Itoh</surname><given-names>C</given-names></name>
<name><surname>Miura</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese</article-title>. <source>Circulation</source> <year>1994</year>; <volume>90</volume>: <fpage>2199</fpage>–<lpage>2202</lpage>.</citation>
</ref>
<ref id="bibr13-1470320311426168">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Winkelmann</surname><given-names>BR</given-names></name>
<name><surname>Nauck</surname><given-names>M</given-names></name>
<name><surname>Klein</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease</article-title>. <source>Ann Intern Med</source> <year>1996</year>; <volume>125</volume>: <fpage>19</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr14-1470320311426168">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yaren</surname><given-names>A</given-names></name>
<name><surname>Turgut</surname><given-names>S</given-names></name>
<name><surname>Kursunluoglu</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients</article-title>. <source>Tohoku J Exp Med</source> <year>2006</year>; <volume>210</volume>: <fpage>109</fpage>–<lpage>116</lpage>.</citation>
</ref>
<ref id="bibr15-1470320311426168">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yaren</surname><given-names>A</given-names></name>
<name><surname>Turgut</surname><given-names>S</given-names></name>
<name><surname>Kursunluoglu</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors</article-title>. <source>J Investig Med</source> <year>2007</year>; <volume>55</volume>: <fpage>255</fpage>–<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr16-1470320311426168">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>JM</given-names></name>
<name><surname>Koh</surname><given-names>WP</given-names></name>
<name><surname>Sun</surname><given-names>CL</given-names></name>
<name><surname>Lee</surname><given-names>HP</given-names></name>
<name><surname>Yu</surname><given-names>MC</given-names></name>
</person-group>. <article-title>Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore</article-title>. <source>Carcinogenesis</source> <year>2005</year>; <volume>26</volume>: <fpage>1389</fpage>–<lpage>1394</lpage>.</citation>
</ref>
<ref id="bibr17-1470320311426168">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koh</surname><given-names>WP</given-names></name>
<name><surname>Yuan</surname><given-names>JM</given-names></name>
<name><surname>Sun</surname><given-names>CL</given-names></name><etal/>
</person-group>. <article-title>Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore</article-title>. <source>Cancer Res</source> <year>2003</year>; <volume>63</volume>: <fpage>573</fpage>–<lpage>578</lpage>.</citation>
</ref>
<ref id="bibr18-1470320311426168">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haiman</surname><given-names>CA</given-names></name>
<name><surname>Henderson</surname><given-names>SO</given-names></name>
<name><surname>Bretsky</surname><given-names>P</given-names></name>
<name><surname>Kolonel</surname><given-names>LN</given-names></name>
<name><surname>Henderson</surname><given-names>BE</given-names></name>
</person-group>. <article-title>Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort</article-title>. <source>Cancer Res</source> <year>2003</year>; <volume>63</volume>: <fpage>6984</fpage>–<lpage>6987</lpage>.</citation>
</ref>
<ref id="bibr19-1470320311426168">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alves Correa</surname><given-names>SA</given-names></name>
<name><surname>Ribeiro</surname><given-names>de</given-names></name>
<name><surname>Noronha</surname><given-names>SM</given-names></name>
<name><surname>Nogueira-de-Souza</surname><given-names>NC</given-names></name><etal/>
</person-group>. <article-title>Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2009</year>; <volume>10</volume>: <fpage>51</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr20-1470320311426168">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koh</surname><given-names>WP</given-names></name>
<name><surname>Yuan</surname><given-names>JM</given-names></name>
<name><surname>Van Den Berg</surname><given-names>D</given-names></name>
<name><surname>Lee</surname><given-names>HP</given-names></name>
<name><surname>Yu</surname><given-names>MC</given-names></name>
</person-group>. <article-title>Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore</article-title>. <source>Carcinogenesis</source> <year>2005</year>; <volume>26</volume>: <fpage>459</fpage>–<lpage>464</lpage>.</citation>
</ref>
<ref id="bibr21-1470320311426168">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gonzalez-Zuloeta Ladd</surname><given-names>AM</given-names></name>
<name><surname>Arias Vasquez</surname><given-names>A</given-names></name>
<name><surname>Sayed-Tabatabaei</surname><given-names>FA</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <year>2005</year>; <volume>14</volume>: <fpage>2143</fpage>–<lpage>2146</lpage>.</citation>
</ref>
<ref id="bibr22-1470320311426168">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sugimoto</surname><given-names>M</given-names></name>
<name><surname>Furuta</surname><given-names>T</given-names></name>
<name><surname>Shirai</surname><given-names>N</given-names></name>
<name><surname>Ikuma</surname><given-names>M</given-names></name>
<name><surname>Sugimura</surname><given-names>H</given-names></name>
<name><surname>Hishida</surname><given-names>A</given-names></name>
</person-group>. <article-title>Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <year>2006</year>; <volume>15</volume>: <fpage>1929</fpage>–<lpage>1934</lpage>.</citation>
</ref>
<ref id="bibr23-1470320311426168">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Röcken</surname><given-names>C</given-names></name>
<name><surname>Rohl</surname><given-names>FW</given-names></name>
<name><surname>Diebler</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <year>2007</year>; <volume>16</volume>: <fpage>1206</fpage>–<lpage>1212</lpage>.</citation>
</ref>
<ref id="bibr24-1470320311426168">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Röcken</surname><given-names>C</given-names></name>
<name><surname>Lendeckel</surname><given-names>U</given-names></name>
<name><surname>Dierkes</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism</article-title>. <source>Clin Cancer Res</source> <year>2005</year>; <volume>11</volume>: <fpage>2526</fpage>–<lpage>2530</lpage>.</citation>
</ref>
<ref id="bibr25-1470320311426168">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ebert</surname><given-names>MP</given-names></name>
<name><surname>Lendeckel</surname><given-names>U</given-names></name>
<name><surname>Westphal</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <year>2005</year>; <volume>14</volume>: <fpage>2987</fpage>–<lpage>2989</lpage>.</citation>
</ref>
<ref id="bibr26-1470320311426168">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goto</surname><given-names>Y</given-names></name>
<name><surname>Ando</surname><given-names>T</given-names></name>
<name><surname>Nishio</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis</article-title>. <source>Asian Pac J Cancer Prev</source> <year>2005</year>; <volume>6</volume>: <fpage>464</fpage>–<lpage>467</lpage>.</citation>
</ref>
<ref id="bibr27-1470320311426168">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toma</surname><given-names>M</given-names></name>
<name><surname>Cimponeriu</surname><given-names>D</given-names></name>
<name><surname>Apostol</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Lack of association between ACE ID polymorphism and colorectal cancer in Romanian patients</article-title>. <source>Chirurgia (Bucur)</source> <year>2009</year>; <volume>104</volume>: <fpage>553</fpage>–<lpage>556</lpage>.</citation>
</ref>
<ref id="bibr28-1470320311426168">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Knaap</surname><given-names>R</given-names></name>
<name><surname>Siemes</surname><given-names>C</given-names></name>
<name><surname>Coebergh</surname><given-names>JW</given-names></name>
<name><surname>van Duijn</surname><given-names>CM</given-names></name>
<name><surname>Hofman</surname><given-names>A</given-names></name>
<name><surname>Stricker</surname><given-names>BH</given-names></name>
</person-group>. <article-title>Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study</article-title>. <source>Cancer</source> <year>2008</year>; <volume>112</volume>: <fpage>748</fpage>–<lpage>757</lpage>.</citation>
</ref>
<ref id="bibr29-1470320311426168">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Röcken</surname><given-names>C</given-names></name>
<name><surname>Neumann</surname><given-names>K</given-names></name>
<name><surname>Carl-McGrath</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients</article-title>. <source>Neoplasia</source> <year>2007</year>; <volume>9</volume>: <fpage>716</fpage>–<lpage>722</lpage>.</citation>
</ref>
<ref id="bibr30-1470320311426168">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nikiteas</surname><given-names>N</given-names></name>
<name><surname>Tsigris</surname><given-names>C</given-names></name>
<name><surname>Chatzitheofylaktou</surname><given-names>A</given-names></name>
<name><surname>Yannopoulos</surname><given-names>A</given-names></name>
</person-group>. <article-title>No association with risk for colorectal cancer of the insertion/deletion polymorphism which affects levels of angiotensin-converting enzyme</article-title>. <source>In Vivo</source> <year>2007</year>; <volume>21</volume>: <fpage>1065</fpage>–<lpage>1068</lpage>.</citation>
</ref>
<ref id="bibr31-1470320311426168">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sameer</surname><given-names>A</given-names></name>
<name><surname>Nissar</surname><given-names>S</given-names></name>
<name><surname>Bashir</surname><given-names>S</given-names></name>
<name><surname>Bashir</surname><given-names>A</given-names></name>
<name><surname>Siddiqi</surname><given-names>M</given-names></name>
</person-group>. <article-title>ACE Polymorphism in Colorectal Cancer Patients of Kashmiri Population - A Short Report</article-title>. <source>The Open Colorectal Cancer Journal</source> <year>2011</year>; <volume>4</volume>: <fpage>1</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr32-1470320311426168">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sierra Diaz</surname><given-names>E</given-names></name>
<name><surname>Sanchez Corona</surname><given-names>J</given-names></name>
<name><surname>Rosales Gomez</surname><given-names>RC</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2009</year>; <volume>10</volume>: <fpage>241</fpage>–<lpage>246</lpage>.</citation>
</ref>
<ref id="bibr33-1470320311426168">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yigit</surname><given-names>B</given-names></name>
<name><surname>Bozkurt</surname><given-names>N</given-names></name>
<name><surname>Narter</surname><given-names>F</given-names></name>
<name><surname>Yilmaz</surname><given-names>H</given-names></name>
<name><surname>Yucebas</surname><given-names>E</given-names></name>
<name><surname>Isbir</surname><given-names>T</given-names></name>
</person-group>. <article-title>Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis</article-title>. <source>Anticancer Res</source> <year>2007</year>; <volume>27</volume>: <fpage>933</fpage>–<lpage>936</lpage>.</citation>
</ref>
<ref id="bibr34-1470320311426168">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Medeiros</surname><given-names>R</given-names></name>
<name><surname>Vasconcelos</surname><given-names>A</given-names></name>
<name><surname>Costa</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer</article-title>. <source>J Pathol</source> <year>2004</year>; <volume>202</volume>: <fpage>330</fpage>–<lpage>335</lpage>.</citation>
</ref>
<ref id="bibr35-1470320311426168">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheon</surname><given-names>KT</given-names></name>
<name><surname>Choi</surname><given-names>KH</given-names></name>
<name><surname>Lee</surname><given-names>HB</given-names></name>
<name><surname>Park</surname><given-names>SK</given-names></name>
<name><surname>Rhee</surname><given-names>YK</given-names></name>
<name><surname>Lee</surname><given-names>YC</given-names></name>
</person-group>. <article-title>Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer</article-title>. <source>Lung</source> <year>2000</year>; <volume>178</volume>: <fpage>351</fpage>–<lpage>360</lpage>.</citation>
</ref>
<ref id="bibr36-1470320311426168">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yaren</surname><given-names>A</given-names></name>
<name><surname>Oztop</surname><given-names>I</given-names></name>
<name><surname>Turgut</surname><given-names>S</given-names></name>
<name><surname>Turgut</surname><given-names>G</given-names></name>
<name><surname>Degirmencioglu</surname><given-names>S</given-names></name>
<name><surname>Demirpence</surname><given-names>M</given-names></name>
</person-group>. <article-title>Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer</article-title>. <source>Exp Biol Med (Maywood)</source> <year>2008</year>; <volume>233</volume>: <fpage>32</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr37-1470320311426168">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vairaktaris</surname><given-names>E</given-names></name>
<name><surname>Yapijakis</surname><given-names>C</given-names></name>
<name><surname>Tsigris</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer</article-title>. <source>Acta Oncol</source> <year>2007</year>; <volume>46</volume>: <fpage>1097</fpage>–<lpage>1102</lpage>.</citation>
</ref>
<ref id="bibr38-1470320311426168">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vairaktaris</surname><given-names>E</given-names></name>
<name><surname>Serefoglou</surname><given-names>Z</given-names></name>
<name><surname>Avgoustidis</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer</article-title>. <source>Oral Oncol</source> <year>2009</year>; <volume>45</volume>: <fpage>247</fpage>–<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr39-1470320311426168">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Usmani</surname><given-names>BA</given-names></name>
<name><surname>Janeczko</surname><given-names>M</given-names></name>
<name><surname>Shen</surname><given-names>R</given-names></name>
<name><surname>Mazumdar</surname><given-names>M</given-names></name>
<name><surname>Papandreou</surname><given-names>CN</given-names></name>
<name><surname>Nanus</surname><given-names>DM</given-names></name>
</person-group>. <article-title>Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer</article-title>. <source>Br J Cancer</source> <year>2000</year>; <volume>82</volume>: <fpage>550</fpage>–<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr40-1470320311426168">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ruggenenti</surname><given-names>P</given-names></name>
<name><surname>Perna</surname><given-names>A</given-names></name>
<name><surname>Zoccali</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen)</article-title>. <source>J Am Soc Nephrol</source> <year>2000</year>; <volume>11</volume>: <fpage>88</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr41-1470320311426168">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chung</surname><given-names>FM</given-names></name>
<name><surname>Yang</surname><given-names>YH</given-names></name>
<name><surname>Chen</surname><given-names>CH</given-names></name>
<name><surname>Lin</surname><given-names>CC</given-names></name>
<name><surname>Shieh</surname><given-names>TY</given-names></name>
</person-group>. <article-title>Angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with risk of oral precancerous lesion in betel quid chewers</article-title>. <source>Br J Cancer</source> <year>2005</year>; <volume>93</volume>: <fpage>602</fpage>–<lpage>606</lpage>.</citation>
</ref>
<ref id="bibr42-1470320311426168">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bauvois</surname><given-names>B</given-names></name>
</person-group>. <article-title>Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?</article-title> <source>Oncogene</source> <year>2004</year>; <volume>23</volume>: <fpage>317</fpage>–<lpage>329</lpage>.</citation>
</ref>
<ref id="bibr43-1470320311426168">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ruiter</surname><given-names>R</given-names></name>
<name><surname>Visser</surname><given-names>LE</given-names></name>
<name><surname>Van Duijn</surname><given-names>CM</given-names></name>
<name><surname>Ch Stricker</surname><given-names>BH</given-names></name>
</person-group>. <article-title>The ACE insertion/deletion polymorphism and risk of cancer, a review and meta-analysis of the literature</article-title>. <source>Curr Cancer Drug Targets</source> <year>2011</year>; <volume>11</volume>: <fpage>421</fpage>–<lpage>430</lpage>.</citation>
</ref>
<ref id="bibr44-1470320311426168">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>JK</given-names></name>
<name><surname>Gong</surname><given-names>YY</given-names></name>
<name><surname>Xie</surname><given-names>L</given-names></name><etal/>
</person-group>. <article-title>Lack of genetic association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and longevity in a Han Chinese population</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2009</year>; <volume>10</volume>: <fpage>115</fpage>–<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr45-1470320311426168">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yan</surname><given-names>C</given-names></name>
<name><surname>Zhan</surname><given-names>J</given-names></name>
<name><surname>Feng</surname><given-names>W</given-names></name>
</person-group>. <article-title>Gene polymorphisms of angiotensin II type 1 receptor and angiotensin-converting enzyme in two ethnic groups living in Zhejiang Province, China</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2005</year>; <volume>6</volume>: <fpage>132</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr46-1470320311426168">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sun</surname><given-names>J</given-names></name>
<name><surname>Fan</surname><given-names>H</given-names></name>
<name><surname>Che</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls</article-title>. <source>BMC Med Genet</source> <year>2009</year>; <volume>10</volume>: <fpage>64</fpage>.</citation>
</ref>
<ref id="bibr47-1470320311426168">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Daimon</surname><given-names>M</given-names></name>
<name><surname>Oizumi</surname><given-names>T</given-names></name>
<name><surname>Saitoh</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>The D allele of the angiotensin-converting enzyme insertion/ deletion (I/D) polymorphism is a risk factor for type 2 diabetes in a population-based Japanese sample</article-title>. <source>Endocr J</source> <year>2003</year>; <volume>50</volume>: <fpage>393</fpage>–<lpage>398</lpage>.</citation>
</ref>
<ref id="bibr48-1470320311426168">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>YH</given-names></name>
<name><surname>Kim</surname><given-names>JH</given-names></name>
<name><surname>Kim</surname><given-names>DK</given-names></name><etal/>
</person-group>. <article-title>Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> <year>2003</year>; <volume>58</volume>: <fpage>227</fpage>–<lpage>231</lpage>.</citation>
</ref>
<ref id="bibr49-1470320311426168">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Panza</surname><given-names>F</given-names></name>
<name><surname>Solfrizzi</surname><given-names>V</given-names></name>
<name><surname>D’Introno</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe</article-title>. <source>Exp Gerontol</source> <year>2003</year>; <volume>38</volume>: <fpage>1015</fpage>–<lpage>1020</lpage>.</citation>
</ref>
<ref id="bibr50-1470320311426168">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blanche</surname><given-names>H</given-names></name>
<name><surname>Cabanne</surname><given-names>L</given-names></name>
<name><surname>Sahbatou</surname><given-names>M</given-names></name>
<name><surname>Thomas</surname><given-names>G</given-names></name>
</person-group>. <article-title>A study of French centenarians: are ACE and APOE associated with longevity?</article-title> <source>C R Acad Sci III</source> <year>2001</year>; <volume>324</volume>: <fpage>129</fpage>–<lpage>135</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>